首页> 美国卫生研究院文献>Journal of Virology >Structures of a Human Papillomavirus (HPV) E6 Polypeptide Bound to MAGUK Proteins: Mechanisms of Targeting Tumor Suppressors by a High-Risk HPV Oncoprotein
【2h】

Structures of a Human Papillomavirus (HPV) E6 Polypeptide Bound to MAGUK Proteins: Mechanisms of Targeting Tumor Suppressors by a High-Risk HPV Oncoprotein

机译:人乳头瘤病毒(HPV)E6多肽的结构绑定到MAGUK蛋白:高风险HPV癌蛋白靶向肿瘤抑制剂的机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human papillomavirus (HPV) E6 oncoprotein targets certain tumor suppressors such as MAGI-1 and SAP97/hDlg for degradation. A short peptide at the C terminus of E6 interacts specifically with the PDZ domains of these tumor suppressors, which is a property unique to high-risk HPVs that are associated with cervical cancer. The detailed recognition mechanisms between HPV E6 and PDZ proteins are unclear. To understand the specific binding of cellular PDZ substrates by HPV E6, we have solved the crystal structures of the complexes containing a peptide from HPV18 E6 bound to three PDZ domains from MAGI-1 and SAP97/Dlg. The complex crystal structures reveal novel features of PDZ peptide recognition that explain why high-risk HPV E6 can specifically target these cellular tumor suppressors for destruction. Moreover, a new peptide-binding loop on these PDZs is identified as interacting with the E6 peptide. Furthermore, we have identified an arginine residue, unique to high-risk HPV E6 but outside the canonical core PDZ recognition motif, that plays an important role in the binding of the PDZs of both MAGI-I and SAP97/Dlg, the mutation of which abolishes E6's ability to degrade the two proteins. Finally, we have identified a dimer form of MAGI-1 PDZ domain 1 in the cocrystal structure with E6 peptide, which may have functional relevance for MAGI-1 activity. In addition to its novel insights into the biochemistry of PDZ interactions, this study is important for understanding HPV-induced oncogenesis; this could provide a basis for developing antiviral and anticancer compounds.
机译:人乳头瘤病毒(HPV)E6癌蛋白靶向某些肿瘤抑制因子(如MAGI-1和SAP97 / hDlg)进行降解。 E6 C端的短肽与这些肿瘤抑制因子的PDZ结构域特异性相互作用,这是与宫颈癌相关的高危HPV特有的特性。 HPV E6和PDZ蛋白之间的详细识别机制尚不清楚。为了了解HPV E6对细胞PDZ底物的特异性结合,我们解决了复合物的晶体结构,该复合物包含HPV18 E6的肽与MAGI-1和SAP97 / Dlg的三个PDZ域结合。复杂的晶体结构揭示了PDZ肽识别的新特征,这解释了为什么高危HPV E6可以特异性靶向这些细胞肿瘤抑制因子进行破坏。而且,在这些PDZ上的新的肽结合环被鉴定为与E6肽相互作用。此外,我们已经确定了高危HPV E6特有的精氨酸残基,但在规范的核心PDZ识别基序之外,在MAGI-1和SAP97 / Dlg的PDZ结合中起着重要作用,废除了E6降解这两种蛋白质的能力。最后,我们在与E6肽共晶的结构中鉴定了MAGI-1 PDZ域1的二聚体形式,这可能与MAGI-1活性具有功能相关性。除了对PDZ相互作用的生物化学有新颖见解外,这项研究对于理解HPV诱导的肿瘤发生也很重要。这可以为开发抗病毒和抗癌化合物提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号